Those who meet any of the following criteria shall not be included in the group: 1. There were serious noninfectious pulmonary diseases, including pulmonary tumor, pulmonary edema, atelectasis, pulmonary embolism, pulmonary eosinophilic infiltration and pulmonary vasculitis, 2. Severe liver and kidney dysfunction: (1) ALT and AST value were more than 10 times higher than the upper limit of normal value, (2) Serum creatinine value was more than 1.5 times higher than the upper limit of normal value, (3) Total bilirubin was more than 2 times the upper limit of normal value, 3. Patients with biliary obstruction, 4. Pregnant women (urine or serum pregnancy test positive) or lactating women, 5. Other subjects considered unsuitable by the researchers for this trial, or the researchers think that there may be any situation that may increase the risk of subjects or interfere with the clinical trial.

Those who meet any of the following criteria shall not be included in the group: 1. There were serious noninfectious pulmonary diseases, including pulmonary tumor, pulmonary edema, atelectasis, pulmonary embolism, pulmonary eosinophilic infiltration and pulmonary vasculitis, 2. Severe liver and kidney dysfunction: (1) ALT and AST value were more than 10 times higher than the upper limit of normal value, (2) Serum creatinine value was more than 1.5 times higher than the upper limit of normal value, (3) Total bilirubin was more than 2 times the upper limit of normal value, 3. Patients with biliary obstruction, 4. Pregnant women (urine or serum pregnancy test positive) or lactating women, 5. Other subjects considered unsuitable by the researchers for this trial, or the researchers think that there may be any situation that may increase the risk of subjects or interfere with the clinical trial.

Those who meet any of the following criteria shall not be included in the group: 1) There were serious noninfectious pulmonary diseases, including pulmonary tumor, pulmonary edema, atelectasis, pulmonary embolism, pulmonary eosinophilic infiltration and pulmonary vasculitis, 2) Severe liver and kidney dysfunction: a) ALT and AST value were more than 10 times higher than the upper limit of normal value, b) Serum creatinine value was more than 1.5 times higher than the upper limit of normal value, c) Total bilirubin was more than 2 times the upper limit of normal value, 3) Patients with biliary obstruction, 4) Pregnant women (urine or serum pregnancy test positive) or lactating women, 5) Other subjects considered unsuitable by the researchers for this trial, or the researchers think that there may be any situation that may increase the risk of subjects or interfere with the clinical trial.

Those who meet any of the following criteria shall not be included in the group: 1) There were serious noninfectious pulmonary diseases, including pulmonary tumor, pulmonary edema, atelectasis, pulmonary embolism, pulmonary eosinophilic infiltration and pulmonary vasculitis, 2) Severe liver and kidney dysfunction: a) ALT and AST value were more than 10 times higher than the upper limit of normal value, b) Serum creatinine value was more than 1.5 times higher than the upper limit of normal value, c) Total bilirubin was more than 2 times the upper limit of normal value, 3) Patients with biliary obstruction, 4) Pregnant women (urine or serum pregnancy test positive) or lactating women, 5) Other subjects considered unsuitable by the researchers for this trial, or the researchers think that there may be any situation that may increase the risk of subjects or interfere with the clinical trial.